MARIA DEL CARMENBEHRENSMARIA DEL CARMEN BEHRENS9131BEHRENS, MARIA DEL CARMENAssistant Professorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson19270647Prudkin L, Liu DD, Ozburn NC, Sun M, Behrens C, Tang X, Brown KC, Bekele BN, Moran C, Wistuba IIModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncEpithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung. Mod Pathol. 2009 May; 22(5):668-78.Mod Pathol2009-03-06T00:00:002009Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung.20023269Solis LM, Raso MG, Kalhor N, Behrens C, Wistuba II, Moran CAAmerican journal of clinical pathologyPrimary oncocytic adenocarcinomas of the lung: a clinicopathologic, immunohistochemical, and molecular biologic analysis of 16 cases. Am J Clin Pathol. 2010 Jan; 133(1):133-40.Am J Clin Pathol2010-01-01T00:00:002010Primary oncocytic adenocarcinomas of the lung: a clinicopathologic, immunohistochemical, and molecular biologic analysis of 16 cases.20161759Yuan P, Kadara H, Behrens C, Tang X, Woods D, Solis LM, Huang J, Spinola M, Dong W, Yin G, Fujimoto J, Kim E, Xie Y, Girard L, Moran C, Hong WK, Minna JD, Wistuba IIPloS oneSex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung. PLoS One. 2010 Feb 09; 5(2):e9112.PLoS One2010-02-09T00:00:002010Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung.20534738Solis LM, Behrens C, Dong W, Suraokar M, Ozburn NC, Moran CA, Corvalan AH, Biswal S, Swisher SG, Bekele BN, Minna JD, Stewart DJ, Wistuba IIClinical cancer research : an official journal of the American Association for Cancer ResearchNrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features. Clin Cancer Res. 2010 Jul 15; 16(14):3743-53.Clin Cancer Res2010-06-09T00:00:002010Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features.21257719Tang X, Kadara H, Behrens C, Liu DD, Xiao Y, Rice D, Gazdar AF, Fujimoto J, Moran C, Varella-Garcia M, Lee JJ, Hong WK, Wistuba IIClinical cancer research : an official journal of the American Association for Cancer ResearchAbnormalities of the TITF-1 lineage-specific oncogene in NSCLC: implications in lung cancer pathogenesis and prognosis. Clin Cancer Res. 2011 Apr 15; 17(8):2434-43.Clin Cancer Res2011-01-21T00:00:002011Abnormalities of the TITF-1 lineage-specific oncogene in NSCLC: implications in lung cancer pathogenesis and prognosis.22020674Solis LM, Behrens C, Raso MG, Lin HY, Kadara H, Yuan P, Galindo H, Tang X, Lee JJ, Kalhor N, Wistuba II, Moran CACancerHistologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome. Cancer. 2012 Jun 01; 118(11):2889-99.Cancer2011-10-21T00:00:002011Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome.22338057Moran CA, Weissferdt A, Kalhor N, Solis LM, Behrens C, Wistuba II, Suster SAmerican journal of clinical pathologyThymomas I: a clinicopathologic correlation of 250 cases with emphasis on the World Health Organization schema. Am J Clin Pathol. 2012 Mar; 137(3):444-50.Am J Clin Pathol2012-03-01T00:00:002012Thymomas I: a clinicopathologic correlation of 250 cases with emphasis on the World Health Organization schema.24048333Wistuba II, Behrens C, Lombardi F, Wagner S, Fujimoto J, Raso MG, Spaggiari L, Galetta D, Riley R, Hughes E, Reid J, Sangale Z, Swisher SG, Kalhor N, Moran CA, Gutin A, Lanchbury JS, Barberis M, Kim ESClinical cancer research : an official journal of the American Association for Cancer ResearchValidation of a proliferation-based expression signature as prognostic marker in early stage lung adenocarcinoma. Clin Cancer Res. 2013 Nov 15; 19(22):6261-71.Clin Cancer Res2013-09-18T00:00:002013Validation of a proliferation-based expression signature as prognostic marker in early stage lung adenocarcinoma.24097870Behrens C, Solis LM, Lin H, Yuan P, Tang X, Kadara H, Riquelme E, Galindo H, Moran CA, Kalhor N, Swisher SG, Simon GR, Stewart DJ, Lee JJ, Wistuba IIClinical cancer research : an official journal of the American Association for Cancer ResearchEZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non-small cell lung carcinoma. Clin Cancer Res. 2013 Dec 01; 19(23):6556-65.Clin Cancer Res2013-10-04T00:00:002013EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non-small cell lung carcinoma.2130 W Holcombe BlvdHouston77030TXAuthorship 1674803Authorship 1680173Authorship 1682804Authorship 1687732Authorship 1691363Authorship 1832615Authorship 1841102Authorship 1852183Authorship 1859734Authorship 1864855Authorship 1866913Authorship 18854510Authorship 1887366Authorship 1887935Authorship 1896252Authorship 1898866Authorship 1906538Authorship 1922315Authorship 1927091Authorship 19323810Authorship 194040210353731Wistuba II, Bryant D, Behrens C, Milchgrub S, Virmani AK, Ashfaq R, Minna JD, Gazdar AFClinical cancer research : an official journal of the American Association for Cancer ResearchComparison of features of human lung cancer cell lines and their corresponding tumors. Clin Cancer Res. 1999 May; 5(5):991-1000.Clin Cancer Res1999-05-01T00:00:001999Comparison of features of human lung cancer cell lines and their corresponding tumors.10479524Wistuba II, Syed S, Behrens C, Duong M, Milchgrub S, Muller CY, Jagirdar J, Gazdar AFGynecologic oncologyComparison of molecular changes in cervical intraepithelial neoplasia in HIV-positive and HIV-indeterminate subjects. Gynecol Oncol. 1999 Sep; 74(3):519-26.Gynecol Oncol1999-09-01T00:00:001999Comparison of molecular changes in cervical intraepithelial neoplasia in HIV-positive and HIV-indeterminate subjects.10667421Maitra A, Tavassoli FA, Albores-Saavedra J, Behrens C, Wistuba II, Bryant D, Weinberg AG, Rogers BB, Saboorian MH, Gazdar AFHuman pathologyMolecular abnormalities associated with secretory carcinomas of the breast. Hum Pathol. 1999 Dec; 30(12):1435-40.Hum Pathol1999-12-01T00:00:001999Molecular abnormalities associated with secretory carcinomas of the breast.10870595Wistuba II, Behrens C, Gazdar AFAIDS patient care and STDsPathogenesis of non-AIDS-defining cancers: a review. AIDS Patient Care STDS. 1999 Jul; 13(7):415-26.AIDS Patient Care STDS1999-07-01T00:00:001999Pathogenesis of non-AIDS-defining cancers: a review.10914700Wistuba II, Berry J, Behrens C, Maitra A, Shivapurkar N, Milchgrub S, Mackay B, Minna JD, Gazdar AFClinical cancer research : an official journal of the American Association for Cancer ResearchMolecular changes in the bronchial epithelium of patients with small cell lung cancer. Clin Cancer Res. 2000 Jul; 6(7):2604-10.Clin Cancer Res2000-07-01T00:00:002000Molecular changes in the bronchial epithelium of patients with small cell lung cancer.21118965Sullivan JP, Spinola M, Dodge M, Raso MG, Behrens C, Gao B, Schuster K, Shao C, Larsen JE, Sullivan LA, Honorio S, Xie Y, Scaglioni PP, DiMaio JM, Gazdar AF, Shay JW, Wistuba II, Minna JDCancer researchAldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling. Cancer Res. 2010 Dec 01; 70(23):9937-48.Cancer Res2010-11-30T00:00:002010Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling.21447628Kim WY, Kim MJ, Moon H, Yuan P, Kim JS, Woo JK, Zhang G, Suh YA, Feng L, Behrens C, Van Pelt CS, Kang H, Lee JJ, Hong WK, Wistuba II, Lee HYEndocrinologyDifferential impacts of insulin-like growth factor-binding protein-3 (IGFBP-3) in epithelial IGF-induced lung cancer development. Endocrinology. 2011 Jun; 152(6):2164-73.Endocrinology2011-03-29T00:00:002011Differential impacts of insulin-like growth factor-binding protein-3 (IGFBP-3) in epithelial IGF-induced lung cancer development.21952750Kim JS, Kim ES, Liu D, Lee JJ, Solis L, Behrens C, Lippman SM, Hong WK, Wistuba II, Lee HYCancerPrognostic impact of insulin receptor expression on survival of patients with nonsmall cell lung cancer. Cancer. 2012 May 01; 118(9):2454-65.Cancer2011-09-22T00:00:002011Prognostic impact of insulin receptor expression on survival of patients with nonsmall cell lung cancer.22102852He Y, Correa AM, Raso MG, Hofstetter WL, Fang B, Behrens C, Roth JA, Zhou Y, Yu L, Wistuba II, Swisher SG, Pataer APloS oneThe role of PKR/eIF2a signaling pathway in prognosis of non-small cell lung cancer. PLoS One. 2011; 6(11):e24855.PLoS One2011-11-10T00:00:002011The role of PKR/eIF2a signaling pathway in prognosis of non-small cell lung cancer.23343765Galluzzi L, Goubar A, Olaussen KA, Vitale I, Senovilla L, Michels J, Robin A, Dorvault N, Besse B, Validire P, Fouret P, Behrens C, Wistuba II, Soria JC, Kroemer GCell cycle (Georgetown, Tex.)Prognostic value of LIPC in non-small cell lung carcinoma. Cell Cycle. 2013 Feb 15; 12(4):647-54.Cell Cycle2013-01-23T00:00:002013Prognostic value of LIPC in non-small cell lung carcinoma.BiostatisticsGI Medical OncologyRadiation OncologyThoracic & Cardiovascular SurgeryThoracic Head & Neck Medical OncologyTranslational Molecular PathologyMD AndersonJOE YCHANGJOE Y CHANG8639CHANG, JOE YProfessorAPARPATAERAPAR PATAER8799PATAER, APARAssociate ProfessorJOHN VICTORHEYMACHJOHN VICTOR HEYMACH9280HEYMACH, JOHN VICTORProfessorJAFFER AAJANIJAFFER A AJANI8473AJANI, JAFFER AProfessorSTEPHEN GSWISHERSTEPHEN G SWISHER8671SWISHER, STEPHEN GProfessor1.722180.00370408497research areas5.398440.022592146coauthor of82.110714.154860similar to11133selected publicationsJIUN-KAE JACKLEEJIUN-KAE JACK LEE8607LEE, JIUN-KAE JACKProfessorCESARMORANCESAR MORAN8985MORAN, CESARProfessorIGNACIO IVANWISTUBAIGNACIO IVAN WISTUBA9098WISTUBA, IGNACIO IVANProfessorAuthorship 2157422Authorship 2165852Authorship 2166933Authorship 2236552Authorship 2247132Authorship 2258343Authorship 2263584Authorship 2269533Authorship 2271452Authorship 2272384Authorship 2294372Authorship 22945911Authorship 2294615Authorship 2297004Authorship 2320357Authorship 2330297Authorship 2332278Authorship 2334425Authorship 2341898Authorship 234266109865903Wistuba II, Behrens C, Milchgrub S, Syed S, Ahmadian M, Virmani AK, Kurvari V, Cunningham TH, Ashfaq R, Minna JD, Gazdar AFClinical cancer research : an official journal of the American Association for Cancer ResearchComparison of features of human breast cancer cell lines and their corresponding tumors. Clin Cancer Res. 1998 Dec; 4(12):2931-8.Clin Cancer Res1998-12-01T00:00:001998Comparison of features of human breast cancer cell lines and their corresponding tumors.9989814Wistuba II, Behrens C, Milchgrub S, Bryant D, Hung J, Minna JD, Gazdar AFOncogeneSequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene. 1999 Jan 21; 18(3):643-50.Oncogene1999-01-21T00:00:001999Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma.10391558Ramnani DM, Wistuba II, Behrens C, Gazdar AF, Sobin LH, Albores-Saavedra JCancerK-ras and p53 mutations in the pathogenesis of classical and goblet cell carcinoids of the appendix. Cancer. 1999 Jul 01; 86(1):14-21.Cancer1999-07-01T00:00:001999K-ras and p53 mutations in the pathogenesis of classical and goblet cell carcinoids of the appendix.17145864Shen J, Behrens C, Wistuba II, Feng L, Lee JJ, Hong WK, Lotan RCancer researchIdentification and validation of differences in protein levels in normal, premalignant, and malignant lung cells and tissues using high-throughput Western Array and immunohistochemistry. Cancer Res. 2006 Dec 01; 66(23):11194-206.Cancer Res2006-12-01T00:00:002006Identification and validation of differences in protein levels in normal, premalignant, and malignant lung cells and tissues using high-throughput Western Array and immunohistochemistry.18089792Jin Q, Feng L, Behrens C, Bekele BN, Wistuba II, Hong WK, Lee HYCancer researchImplication of AMP-activated protein kinase and Akt-regulated survivin in lung cancer chemopreventive activities of deguelin. Cancer Res. 2007 Dec 15; 67(24):11630-9.Cancer Res2007-12-15T00:00:002007Implication of AMP-activated protein kinase and Akt-regulated survivin in lung cancer chemopreventive activities of deguelin.18172250Prudkin L, Behrens C, Liu DD, Zhou X, Ozburn NC, Bekele BN, Minna JD, Moran C, Roth JA, Ji L, Wistuba IIClinical cancer research : an official journal of the American Association for Cancer ResearchLoss and reduction of FUS1 protein expression is a frequent phenomenon in the pathogenesis of lung cancer. Clin Cancer Res. 2008 Jan 01; 14(1):41-7.Clin Cancer Res2008-01-01T00:00:002008Loss and reduction of FUS1 protein expression is a frequent phenomenon in the pathogenesis of lung cancer.18698353Deus HF, Stanislaus R, Veiga DF, Behrens C, Wistuba II, Minna JD, Garner HR, Swisher SG, Roth JA, Correa AM, Broom B, Coombes K, Chang A, Vogel LH, Almeida JSPloS oneA Semantic Web management model for integrative biomedical informatics. PLoS One. 2008 Aug 13; 3(8):e2946.PLoS One2008-08-13T00:00:002008A Semantic Web management model for integrative biomedical informatics.18999102Deus HF, Stanislaus R, Behrens C, Wistuba II, Minna JD, Garner HR, Swisher SG, Roth JA, Correa AM, Broom B, Coombes K, Almeida JSAMIA ... Annual Symposium proceedings. AMIA SymposiumData driven semantic integration of translational lung cancer research at MDAnderson Cancer Center. AMIA Annu Symp Proc. 2008 Nov 06; 927.AMIA Annu Symp Proc2008-11-06T00:00:002008Data driven semantic integration of translational lung cancer research at MDAnderson Cancer Center.19531623Brannan JM, Dong W, Prudkin L, Behrens C, Lotan R, Bekele BN, Wistuba I, Johnson FMClinical cancer research : an official journal of the American Association for Cancer ResearchExpression of the receptor tyrosine kinase EphA2 is increased in smokers and predicts poor survival in non-small cell lung cancer. Clin Cancer Res. 2009 Jul 01; 15(13):4423-30.Clin Cancer Res2009-06-16T00:00:002009Expression of the receptor tyrosine kinase EphA2 is increased in smokers and predicts poor survival in non-small cell lung cancer.19638491Kadara H, Lacroix L, Behrens C, Solis L, Gu X, Lee JJ, Tahara E, Lotan D, Hong WK, Wistuba II, Lotan RCancer prevention research (Philadelphia, Pa.)Identification of gene signatures and molecular markers for human lung cancer prognosis using an in vitro lung carcinogenesis system. Cancer Prev Res (Phila). 2009 Aug; 2(8):702-11.Cancer Prev Res (Phila)2009-07-28T00:00:002009Identification of gene signatures and molecular markers for human lung cancer prognosis using an in vitro lung carcinogenesis system.20627364Stewart DJ, Behrens C, Roth J, Wistuba IILung cancer (Amsterdam, Netherlands)Exponential decay nonlinear regression analysis of patient survival curves: preliminary assessment in non-small cell lung cancer. Lung Cancer. 2011 Feb; 71(2):217-23.Lung Cancer2011-02-01T00:00:002011Exponential decay nonlinear regression analysis of patient survival curves: preliminary assessment in non-small cell lung cancer.21540235Damelin M, Geles KG, Follettie MT, Yuan P, Baxter M, Golas J, DiJoseph JF, Karnoub M, Huang S, Diesl V, Behrens C, Choe SE, Rios C, Gruzas J, Sridharan L, Dougher M, Kunz A, Hamann PR, Evans D, Armellino D, Khandke K, Marquette K, Tchistiakova L, Boghaert ER, Abraham RT, Wistuba II, Zhou BBCancer researchDelineation of a cellular hierarchy in lung cancer reveals an oncofetal antigen expressed on tumor-initiating cells. Cancer Res. 2011 Jun 15; 71(12):4236-46.Cancer Res2011-05-03T00:00:002011Delineation of a cellular hierarchy in lung cancer reveals an oncofetal antigen expressed on tumor-initiating cells.21540238Ponz-Sarvis? M, Nguewa PA, Pajares MJ, Agorreta J, Lozano MD, Redrado M, Pio R, Behrens C, Wistuba II, Garc?a-Franco CE, Garc?a-Foncillas J, Montuenga LM, Calvo A, Gil-Bazo IClinical cancer research : an official journal of the American Association for Cancer ResearchInhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance. Clin Cancer Res. 2011 Jun 15; 17(12):4155-66.Clin Cancer Res2011-05-03T00:00:002011Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance.21742808Xie Y, Xiao G, Coombes KR, Behrens C, Solis LM, Raso G, Girard L, Erickson HS, Roth J, Heymach JV, Moran C, Danenberg K, Minna JD, Wistuba IIClinical cancer research : an official journal of the American Association for Cancer ResearchRobust gene expression signature from formalin-fixed paraffin-embedded samples predicts prognosis of non-small-cell lung cancer patients. Clin Cancer Res. 2011 Sep 01; 17(17):5705-14.Clin Cancer Res2011-07-08T00:00:002011Robust gene expression signature from formalin-fixed paraffin-embedded samples predicts prognosis of non-small-cell lung cancer patients.22481232Pataer A, Kalhor N, Correa AM, Raso MG, Erasmus JJ, Kim ES, Behrens C, Lee JJ, Roth JA, Stewart DJ, Vaporciyan AA, Wistuba II, Swisher SG, University of Texas M. D. Anderson Lung Cancer Collaborative Research GroupJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerHistopathologic response criteria predict survival of patients with resected lung cancer after neoadjuvant chemotherapy. J Thorac Oncol. 2012 May; 7(5):825-32.J Thorac Oncol2012-05-01T00:00:002012Histopathologic response criteria predict survival of patients with resected lung cancer after neoadjuvant chemotherapy.22700587Jeong Y, Xie Y, Lee W, Bookout AL, Girard L, Raso G, Behrens C, Wistuba II, Gadzar AF, Minna JD, Mangelsdorf DJMolecular endocrinology (Baltimore, Md.)Research resource: Diagnostic and therapeutic potential of nuclear receptor expression in lung cancer. Mol Endocrinol. 2012 Aug; 26(8):1443-54.Mol Endocrinol2012-06-14T00:00:002012Research resource: Diagnostic and therapeutic potential of nuclear receptor expression in lung cancer.23773262Vanhecke E, Valent A, Tang X, Vielh P, Friboulet L, Tang T, Goubar A, Li Y, Robin A, Behrens C, Commo F, Validire P, Andr? F, Wistuba II, Soria JC, Olaussen KAClinical lung cancer19q13-ERCC1 gene copy number increase in non--small-cell lung cancer. Clin Lung Cancer. 2013 Sep; 14(5):549-57.Clin Lung Cancer2013-06-15T00:00:00201319q13-ERCC1 gene copy number increase in non--small-cell lung cancer.24052020Pyo J, Won Kim K, Jacene HA, Sakellis CG, Brown JR, Van den Abbeele ADClinical cancer research : an official journal of the American Association for Cancer ResearchEnd-therapy positron emission tomography for treatment response assessment in follicular lymphoma: a systematic review and meta-analysis. Clin Cancer Res. 2013 Dec 01; 19(23):6566-77.Clin Cancer Res2013-09-19T00:00:002013End-therapy positron emission tomography for treatment response assessment in follicular lymphoma: a systematic review and meta-analysis.24284056Cumberbatch M, Tang X, Beran G, Eckersley S, Wang X, Ellston RP, Dearden S, Cosulich S, Smith PD, Behrens C, Kim ES, Su X, Fan S, Gray N, Blowers DP, Wistuba II, Womack CClinical cancer research : an official journal of the American Association for Cancer ResearchIdentification of a subset of human non-small cell lung cancer patients with high PI3K? and low PTEN expression, more prevalent in squamous cell carcinoma. Clin Cancer Res. 2014 Feb 01; 20(3):595-603.Clin Cancer Res2013-11-27T00:00:002013Identification of a subset of human non-small cell lung cancer patients with high PI3K? and low PTEN expression, more prevalent in squamous cell carcinoma.24486591Delgado O, Batten KG, Richardson JA, Xie XJ, Gazdar AF, Kaisani AA, Girard L, Behrens C, Suraokar M, Fasciani G, Wright WE, Story MD, Wistuba II, Minna JD, Shay JWClinical cancer research : an official journal of the American Association for Cancer ResearchRadiation-enhanced lung cancer progression in a transgenic mouse model of lung cancer is predictive of outcomes in human lung and breast cancer. Clin Cancer Res. 2014 Mar 15; 20(6):1610-22.Clin Cancer Res2014-01-31T00:00:002014Radiation-enhanced lung cancer progression in a transgenic mouse model of lung cancer is predictive of outcomes in human lung and breast cancer.25808870Hu S, Danilov AV, Godek K, Orr B, Tafe LJ, Rodriguez-Canales J, Behrens C, Mino B, Moran CA, Memoli VA, Mustachio LM, Galimberti F, Ravi S, DeCastro A, Lu Y, Sekula D, Andrew AS, Wistuba II, Freemantle S, Compton DA, Dmitrovsky ECancer researchCDK2 Inhibition Causes Anaphase Catastrophe in Lung Cancer through the Centrosomal Protein CP110. Cancer Res. 2015 May 15; 75(10):2029-38.Cancer Res2015-03-25T00:00:002015CDK2 Inhibition Causes Anaphase Catastrophe in Lung Cancer through the Centrosomal Protein CP110.Authorship 2404033Authorship 2406752Authorship 2407324Authorship 2407913Authorship 2416412Authorship 2431232Authorship 2438742Authorship 2450182Authorship 2491145Authorship 2529021Authorship 2539652Authorship 2540812Authorship 2542428Authorship 2547365Authorship 2550264Authorship 2556362Authorship 2558135Authorship 2575349Authorship 25894113Authorship 25909840Authorship 2597264Authorship 2600243Authorship 2604944Authorship 2608277Authorship 2611092Authorship 26171759288768Ahmadian M, Wistuba II, Fong KM, Behrens C, Kodagoda DR, Saboorian MH, Shay J, Tomlinson GE, Blum J, Minna JD, Gazdar AFCancer researchAnalysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands. Cancer Res. 1997 Sep 01; 57(17):3664-8.Cancer Res1997-09-01T00:00:001997Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.9308707Wistuba II, Lam S, Behrens C, Virmani AK, Fong KM, LeRiche J, Samet JM, Srivastava S, Minna JD, Gazdar AFJournal of the National Cancer InstituteMolecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst. 1997 Sep 17; 89(18):1366-73.J Natl Cancer Inst1997-09-17T00:00:001997Molecular damage in the bronchial epithelium of current and former smokers.9889022Wistuba II, Thomas B, Behrens C, Onuki N, Lindberg G, Albores-Saavedra J, Gazdar AFGynecologic oncologyMolecular abnormalities associated with endocrine tumors of the uterine cervix. Gynecol Oncol. 1999 Jan; 72(1):3-9.Gynecol Oncol1999-01-01T00:00:001999Molecular abnormalities associated with endocrine tumors of the uterine cervix.10213509Wistuba II, Behrens C, Virmani AK, Milchgrub S, Syed S, Lam S, Mackay B, Minna JD, Gazdar AFCancer researchAllelic losses at chromosome 8p21-23 are early and frequent events in the pathogenesis of lung cancer. Cancer Res. 1999 Apr 15; 59(8):1973-9.Cancer Res1999-04-15T00:00:001999Allelic losses at chromosome 8p21-23 are early and frequent events in the pathogenesis of lung cancer.10766185Wistuba II, Behrens C, Virmani AK, Mele G, Milchgrub S, Girard L, Fondon JW, Garner HR, McKay B, Latif F, Lerman MI, Lam S, Gazdar AF, Minna JDCancer researchHigh resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res. 2000 Apr 01; 60(7):1949-60.Cancer Res2000-04-01T00:00:002000High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.11745069Huang J, Behrens C, Wistuba I, Gazdar AF, Jagirdar JAnnals of diagnostic pathologyMolecular analysis of synchronous and metachronous tumors of the lung: impact on management and prognosis. Ann Diagn Pathol. 2001 Dec; 5(6):321-9.Ann Diagn Pathol2001-12-01T00:00:002001Molecular analysis of synchronous and metachronous tumors of the lung: impact on management and prognosis.11900568Huang J, Behrens C, Wistuba II, Gazdar AF, Jagirdar JArchives of pathology & laboratory medicineClonality of combined tumors. Arch Pathol Lab Med. 2002 Apr; 126(4):437-41.Arch Pathol Lab Med2002-04-01T00:00:002002Clonality of combined tumors.14506148Wistuba II, Behrens C, Albores-Saavedra J, Delgado R, Lopez F, Gazdar AFClinical cancer research : an official journal of the American Association for Cancer ResearchDistinct K-ras mutation pattern characterizes signet ring cell colorectal carcinoma. Clin Cancer Res. 2003 Sep 01; 9(10 Pt 1):3615-9.Clin Cancer Res2003-09-01T00:00:002003Distinct K-ras mutation pattern characterizes signet ring cell colorectal carcinoma.17078054Tang X, Liu D, Shishodia S, Ozburn N, Behrens C, Lee JJ, Hong WK, Aggarwal BB, Wistuba IICancerNuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions. Cancer. 2006 Dec 01; 107(11):2637-46.Cancer2006-12-01T00:00:002006Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions.19622585Sun M, Behrens C, Feng L, Ozburn N, Tang X, Yin G, Komaki R, Varella-Garcia M, Hong WK, Aldape KD, Wistuba IIClinical cancer research : an official journal of the American Association for Cancer ResearchHER family receptor abnormalities in lung cancer brain metastases and corresponding primary tumors. Clin Cancer Res. 2009 Aug 01; 15(15):4829-37.Clin Cancer Res2009-07-21T00:00:002009HER family receptor abnormalities in lung cancer brain metastases and corresponding primary tumors.19706809Raso MG, Behrens C, Herynk MH, Liu S, Prudkin L, Ozburn NC, Woods DM, Tang X, Mehran RJ, Moran C, Lee JJ, Wistuba IIClinical cancer research : an official journal of the American Association for Cancer ResearchImmunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutation. Clin Cancer Res. 2009 Sep 01; 15(17):5359-68.Clin Cancer Res2009-08-25T00:00:002009Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutation.19738076Kim WY, Jin Q, Oh SH, Kim ES, Yang YJ, Lee DH, Feng L, Behrens C, Prudkin L, Miller YE, Lee JJ, Lippman SM, Hong WK, Wistuba II, Lee HYCancer researchElevated epithelial insulin-like growth factor expression is a risk factor for lung cancer development. Cancer Res. 2009 Sep 15; 69(18):7439-48.Cancer Res2009-09-08T00:00:002009Elevated epithelial insulin-like growth factor expression is a risk factor for lung cancer development.19934338Brannan JM, Sen B, Saigal B, Prudkin L, Behrens C, Solis L, Dong W, Bekele BN, Wistuba I, Johnson FMCancer prevention research (Philadelphia, Pa.)EphA2 in the early pathogenesis and progression of non-small cell lung cancer. Cancer Prev Res (Phila). 2009 Dec; 2(12):1039-49.Cancer Prev Res (Phila)2009-11-24T00:00:002009EphA2 in the early pathogenesis and progression of non-small cell lung cancer.20028769Behrens C, Feng L, Kadara H, Kim HJ, Lee JJ, Mehran R, Hong WK, Lotan R, Wistuba IIClinical cancer research : an official journal of the American Association for Cancer ResearchExpression of interleukin-1 receptor-associated kinase-1 in non-small cell lung carcinoma and preneoplastic lesions. Clin Cancer Res. 2010 Jan 01; 16(1):34-44.Clin Cancer Res2009-12-22T00:00:002009Expression of interleukin-1 receptor-associated kinase-1 in non-small cell lung carcinoma and preneoplastic lesions.21163870Kadara H, Behrens C, Yuan P, Solis L, Liu D, Gu X, Minna JD, Lee JJ, Kim E, Hong WK, Wistuba II, Lotan RClinical cancer research : an official journal of the American Association for Cancer ResearchA five-gene and corresponding protein signature for stage-I lung adenocarcinoma prognosis. Clin Cancer Res. 2011 Mar 15; 17(6):1490-501.Clin Cancer Res2010-12-16T00:00:002010A five-gene and corresponding protein signature for stage-I lung adenocarcinoma prognosis.21179495Jeong Y, Xie Y, Xiao G, Behrens C, Girard L, Wistuba II, Minna JD, Mangelsdorf DJPLoS medicineNuclear receptor expression defines a set of prognostic biomarkers for lung cancer. PLoS Med. 2010 Dec 14; 7(12):e1000378.PLoS Med2010-12-14T00:00:002010Nuclear receptor expression defines a set of prognostic biomarkers for lung cancer.21430184William WN, Kim JS, Liu DD, Solis L, Behrens C, Lee JJ, Lippman SM, Kim ES, Hong WK, Wistuba II, Lee HYAnnals of oncology : official journal of the European Society for Medical OncologyThe impact of phosphorylated AMP-activated protein kinase expression on lung cancer survival. Ann Oncol. 2012 Jan; 23(1):78-85.Ann Oncol2011-03-23T00:00:002011The impact of phosphorylated AMP-activated protein kinase expression on lung cancer survival.22629454Lockwood WW, Wilson IM, Coe BP, Chari R, Pikor LA, Thu KL, Solis LM, Nunez MI, Behrens C, Yee J, English J, Murray N, Tsao MS, Minna JD, Gazdar AF, Wistuba II, MacAulay CE, Lam S, Lam WLPloS oneDivergent genomic and epigenomic landscapes of lung cancer subtypes underscore the selection of different oncogenic pathways during tumor development. PLoS One. 2012; 7(5):e37775.PLoS One2012-05-21T00:00:002012Divergent genomic and epigenomic landscapes of lung cancer subtypes underscore the selection of different oncogenic pathways during tumor development.22854025Galluzzi L, Vitale I, Senovilla L, Olaussen KA, Pinna G, Eisenberg T, Goubar A, Martins I, Michels J, Kratassiouk G, Carmona-Gutierrez D, Scoazec M, Vacchelli E, Schlemmer F, Kepp O, Shen S, Tailler M, Niso-Santano M, Morselli E, Criollo A, Adjemian S, Jema? M, Chaba K, Pailleret C, Michaud M, Pietrocola F, Tajeddine N, de La Motte Rouge T, Araujo N, Morozova N, Robert T, Ripoche H, Commo F, Besse B, Validire P, Fouret P, Robin A, Dorvault N, Girard P, Gouy S, Pautier P, J?gemann N, Nickel AC, Marsili S, Paccard C, Servant N, Hup? P, Behrens C, Behnam-Motlagh P, Kohno K, Cremer I, Damotte D, Alifano M, Midttun O, Ueland PM, Lazar V, Dessen P, Zischka H, Chatelut E, Castedo M, Madeo F, Barillot E, Thomale J, Wistuba II, Saut?s-Fridman C, Zitvogel L, Soria JC, Harel-Bellan A, Kroemer GCell reportsPrognostic impact of vitamin B6 metabolism in lung cancer. Cell Rep. 2012 Aug 30; 2(2):257-69.Cell Rep2012-07-26T00:00:002012Prognostic impact of vitamin B6 metabolism in lung cancer.23204236Saintigny P, Massarelli E, Lin S, Ahn YH, Chen Y, Goswami S, Erez B, O'Reilly MS, Liu D, Lee JJ, Zhang L, Ping Y, Behrens C, Solis Soto LM, Heymach JV, Kim ES, Herbst RS, Lippman SM, Wistuba II, Hong WK, Kurie JM, Koo JSCancer researchCXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma. Cancer Res. 2013 Jan 15; 73(2):571-82.Cancer Res2012-11-30T00:00:002012CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma.23357979Tang H, Xiao G, Behrens C, Schiller J, Allen J, Chow CW, Suraokar M, Corvalan A, Mao J, White MA, Wistuba II, Minna JD, Xie YClinical cancer research : an official journal of the American Association for Cancer ResearchA 12-gene set predicts survival benefits from adjuvant chemotherapy in non-small cell lung cancer patients. Clin Cancer Res. 2013 Mar 15; 19(6):1577-86.Clin Cancer Res2013-01-28T00:00:002013A 12-gene set predicts survival benefits from adjuvant chemotherapy in non-small cell lung cancer patients.23358651Konstantinidou G, Ramadori G, Torti F, Kangasniemi K, Ramirez RE, Cai Y, Behrens C, Dellinger MT, Brekken RA, Wistuba II, Heguy A, Teruya-Feldstein J, Scaglioni PPCancer discoveryRHOA-FAK is a required signaling axis for the maintenance of KRAS-driven lung adenocarcinomas. Cancer Discov. 2013 Apr; 3(4):444-57.Cancer Discov2013-01-28T00:00:002013RHOA-FAK is a required signaling axis for the maintenance of KRAS-driven lung adenocarcinomas.23370317Guo C, Shao R, Correa AM, Behrens C, Johnson FM, Raso MG, Prudkin L, Solis LM, Nunez MI, Fang B, Roth JA, Wistuba II, Swisher SG, Lin T, Pataer AJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerPrognostic significance of combinations of RNA-dependent protein kinase and EphA2 biomarkers for NSCLC. J Thorac Oncol. 2013 Mar; 8(3):301-8.J Thorac Oncol2013-03-01T00:00:002013Prognostic significance of combinations of RNA-dependent protein kinase and EphA2 biomarkers for NSCLC.24366692Gold KA, Kim ES, Liu DD, Yuan P, Behrens C, Solis LM, Kadara H, Rice DC, Wistuba II, Swisher SG, Hofstetter WL, Lee JJ, Hong WKClinical cancer research : an official journal of the American Association for Cancer ResearchPrediction of survival in resected non-small cell lung cancer using a protein expression-based risk model: implications for personalized chemoprevention and therapy. Clin Cancer Res. 2014 Apr 01; 20(7):1946-54.Clin Cancer Res2013-12-23T00:00:002013Prediction of survival in resected non-small cell lung cancer using a protein expression-based risk model: implications for personalized chemoprevention and therapy.24481402Pajares MJ, Agorreta J, Salvo E, Behrens C, Wistuba II, Montuenga LM, Pio R, Rouzaut ABritish journal of cancerTGFBI expression is an independent predictor of survival in adjuvant-treated lung squamous cell carcinoma patients. Br J Cancer. 2014 Mar 18; 110(6):1545-51.Br J Cancer2014-01-30T00:00:002014TGFBI expression is an independent predictor of survival in adjuvant-treated lung squamous cell carcinoma patients.24662455Stewart DJ, Nunez MI, Behrens C, Liu D, Lin YH, Lee JJ, Roth J, Heymach J, Swisher SG, Hong WK, Wistuba IIJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerMembrane carbonic anhydrase IX expression and relapse risk in resected stage I-II non-small-cell lung cancer. J Thorac Oncol. 2014 May; 9(5):675-84.J Thorac Oncol2014-05-01T00:00:002014Membrane carbonic anhydrase IX expression and relapse risk in resected stage I-II non-small-cell lung cancer.Authorship 2645862Authorship 2646543Authorship 2653131Authorship 2694574Authorship 2701229Authorship 2701464Authorship 27117511Authorship 27135211Authorship 27186111Authorship 27212069605900Wistuba II, Behrens C, Milchgrub S, Virmani AK, Jagirdar J, Thomas B, Ioachim HL, Litzky LA, Brambilla EM, Minna JD, Gazdar AFJAMAComparison of molecular changes in lung cancers in HIV-positive and HIV-indeterminate subjects. JAMA. 1998 May 20; 279(19):1554-9.JAMA1998-05-20T00:00:001998Comparison of molecular changes in lung cancers in HIV-positive and HIV-indeterminate subjects.10862044Wistuba II, Tomlinson GE, Behrens C, Virmani A, Geradts J, Blum JL, Minna JD, Gazdar AFGenes, chromosomes & cancerTwo identical triplet sisters carrying a germline BRCA1 gene mutation acquire very similar breast cancer somatic mutations at multiple other sites throughout the genome. Genes Chromosomes Cancer. 2000 Aug; 28(4):359-69.Genes Chromosomes Cancer2000-08-01T00:00:002000Two identical triplet sisters carrying a germline BRCA1 gene mutation acquire very similar breast cancer somatic mutations at multiple other sites throughout the genome.11045784Behrens C, Travis LB, Wistuba II, Davis S, Maitra A, Clarke EA, Lynch CF, Glimelius B, Wiklund T, Tarone R, Gazdar AFCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive OncologyMolecular changes in second primary lung and breast cancers after therapy for Hodgkin's disease. Cancer Epidemiol Biomarkers Prev. 2000 Oct; 9(10):1027-35.Cancer Epidemiol Biomarkers Prev2000-10-01T00:00:002000Molecular changes in second primary lung and breast cancers after therapy for Hodgkin's disease.20930042Pataer A, Raso MG, Correa AM, Behrens C, Tsuta K, Solis L, Fang B, Roth JA, Wistuba II, Swisher SGClinical cancer research : an official journal of the American Association for Cancer ResearchPrognostic significance of RNA-dependent protein kinase on non-small cell lung cancer patients. Clin Cancer Res. 2010 Nov 15; 16(22):5522-8.Clin Cancer Res2010-10-07T00:00:002010Prognostic significance of RNA-dependent protein kinase on non-small cell lung cancer patients.21724587Yang F, Tang X, Riquelme E, Behrens C, Nilsson MB, Giri U, Varella-Garcia M, Byers LA, Lin HY, Wang J, Raso MG, Girard L, Coombes K, Lee JJ, Herbst RS, Minna JD, Heymach JV, Wistuba IICancer researchIncreased VEGFR-2 gene copy is associated with chemoresistance and shorter survival in patients with non-small-cell lung carcinoma who receive adjuvant chemotherapy. Cancer Res. 2011 Aug 15; 71(16):5512-21.Cancer Res2011-07-01T00:00:002011Increased VEGFR-2 gene copy is associated with chemoresistance and shorter survival in patients with non-small-cell lung carcinoma who receive adjuvant chemotherapy.22355056Pajares MJ, Agorreta J, Larrayoz M, Vesin A, Ezponda T, Zudaire I, Torre W, Lozano MD, Brambilla E, Brambilla C, Wistuba II, Behrens C, Timsit JF, Pio R, Field JK, Montuenga LMJournal of clinical oncology : official journal of the American Society of Clinical OncologyExpression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung. J Clin Oncol. 2012 Apr 01; 30(10):1129-36.J Clin Oncol2012-02-21T00:00:002012Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung.23087048Kadara H, Shen L, Fujimoto J, Saintigny P, Chow CW, Lang W, Chu Z, Garcia M, Kabbout M, Fan YH, Behrens C, Liu DA, Mao L, Lee JJ, Gold KA, Wang J, Coombes KR, Kim ES, Hong WK, Wistuba IICancer prevention research (Philadelphia, Pa.)Characterizing the molecular spatial and temporal field of injury in early-stage smoker non-small cell lung cancer patients after definitive surgery by expression profiling. Cancer Prev Res (Phila). 2013 Jan; 6(1):8-17.Cancer Prev Res (Phila)2012-10-19T00:00:002012Characterizing the molecular spatial and temporal field of injury in early-stage smoker non-small cell lung cancer patients after definitive surgery by expression profiling.23659968Kabbout M, Garcia MM, Fujimoto J, Liu DD, Woods D, Chow CW, Mendoza G, Momin AA, James BP, Solis L, Behrens C, Lee JJ, Wistuba II, Kadara HClinical cancer research : an official journal of the American Association for Cancer ResearchETS2 mediated tumor suppressive function and MET oncogene inhibition in human non-small cell lung cancer. Clin Cancer Res. 2013 Jul 01; 19(13):3383-95.Clin Cancer Res2013-05-09T00:00:002013ETS2 mediated tumor suppressive function and MET oncogene inhibition in human non-small cell lung cancer.24395821Pop LM, Barman S, Shao C, Poe JC, Venturi GM, Shelton JM, Pop IV, Gerber DE, Girard L, Liu XY, Behrens C, Rodriguez-Canales J, Liu H, Wistuba II, Richardson JA, Minna JD, Tedder TF, Vitetta ESCancer researchA reevaluation of CD22 expression in human lung cancer. Cancer Res. 2014 Jan 01; 74(1):263-71.Cancer Res2014-01-01T00:00:002014A reevaluation of CD22 expression in human lung cancer.24485233Kim JS, Kim ES, Liu D, Lee JJ, Solis L, Behrens C, Lippman SM, Hong WK, Wistuba II, Lee HYClinical lung cancerPrognostic implications of tumoral expression of insulin like growth factors 1 and 2 in patients with non-small-cell lung cancer. Clin Lung Cancer. 2014 May; 15(3):213-21.Clin Lung Cancer2014-01-01T00:00:002014Prognostic implications of tumoral expression of insulin like growth factors 1 and 2 in patients with non-small-cell lung cancer.Authorship 2750742Authorship 275234118829480Behrens C, Lin HY, Lee JJ, Raso MG, Hong WK, Wistuba II, Lotan RClinical cancer research : an official journal of the American Association for Cancer ResearchImmunohistochemical expression of basic fibroblast growth factor and fibroblast growth factor receptors 1 and 2 in the pathogenesis of lung cancer. Clin Cancer Res. 2008 Oct 01; 14(19):6014-22.Clin Cancer Res2008-10-01T00:00:002008Immunohistochemical expression of basic fibroblast growth factor and fibroblast growth factor receptors 1 and 2 in the pathogenesis of lung cancer.22729036Nunez MI, Behrens C, Woods DM, Lin H, Suraokar M, Kadara H, Hofstetter W, Kalhor N, Lee JJ, Franklin W, Stewart DJ, Wistuba IIJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerHigh expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutation. J Thorac Oncol. 2012 May; 7(5):833-40.J Thorac Oncol2012-05-01T00:00:002012High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutation.Authorship 28415616Authorship 2842302Authorship 28439412Authorship 28480410Authorship 2855779Authorship 3150567Authorship 315254116983685Mukherjee O, Pastor P, Cairns NJ, Chakraverty S, Kauwe JS, Shears S, Behrens MI, Budde J, Hinrichs AL, Norton J, Levitch D, Taylor-Reinwald L, Gitcho M, Tu PH, Tenenholz Grinberg L, Liscic RM, Armendariz J, Morris JC, Goate AMAnnals of neurologyHDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin. Ann Neurol. 2006 Sep; 60(3):314-22.Ann Neurol2006-09-01T00:00:002006HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin.17334266Behrens MI, Mukherjee O, Tu PH, Liscic RM, Grinberg LT, Carter D, Paulsmeyer K, Taylor-Reinwald L, Gitcho M, Norton JB, Chakraverty S, Goate AM, Morris JC, Cairns NJAlzheimer disease and associated disordersNeuropathologic heterogeneity in HDDD1: a familial frontotemporal lobar degeneration with ubiquitin-positive inclusions and progranulin mutation. Alzheimer Dis Assoc Disord. 2007 Jan-Mar; 21(1):1-7.Alzheimer Dis Assoc Disord2007-01-01T00:00:002007Neuropathologic heterogeneity in HDDD1: a familial frontotemporal lobar degeneration with ubiquitin-positive inclusions and progranulin mutation.20683840Behrens MI, Br?ggemann N, Chana P, Venegas P, K?gi M, Parrao T, Orellana P, Garrido C, Rojas CV, Hauke J, Hahnen E, Gonz?lez R, Seleme N, Fern?ndez V, Schmidt A, Binkofski F, K?mpf D, Kubisch C, Hagenah J, Klein C, Ramirez AMovement disorders : official journal of the Movement Disorder SocietyClinical spectrum of Kufor-Rakeb syndrome in the Chilean kindred with ATP13A2 mutations. Mov Disord. 2010 Sep 15; 25(12):1929-37.Mov Disord2010-09-15T00:00:002010Clinical spectrum of Kufor-Rakeb syndrome in the Chilean kindred with ATP13A2 mutations.20842691Machner B, Sprenger A, Behrens MI, Ramirez A, Br?ggemann N, Klein C, Helmchen CMovement disorders : official journal of the Movement Disorder SocietyEye movement disorders in ATP13A2 mutation carriers (PARK9). Mov Disord. 2010 Nov 15; 25(15):2687-9.Mov Disord2010-11-15T00:00:002010Eye movement disorders in ATP13A2 mutation carriers (PARK9).21060012Br?ggemann N, Hagenah J, Reetz K, Schmidt A, Kasten M, Buchmann I, Eckerle S, B?hre M, M?nchau A, Djarmati A, van der Vegt J, Siebner H, Binkofski F, Ramirez A, Behrens MI, Klein CArchives of neurologyRecessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype. Arch Neurol. 2010 Nov; 67(11):1357-63.Arch Neurol2010-11-01T00:00:002010Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype.21498432Behrens MI, Silva M, Schmied A, Salech F, Manzur H, Rebolledo R, Bull R, Torres V, Henriquez M, Quest AFThe journals of gerontology. Series A, Biological sciences and medical sciencesAge-dependent increases in apoptosis/necrosis ratios in human lymphocytes exposed to oxidative stress. J Gerontol A Biol Sci Med Sci. 2011 Jul; 66(7):732-40.J Gerontol A Biol Sci Med Sci2011-04-15T00:00:002011Age-dependent increases in apoptosis/necrosis ratios in human lymphocytes exposed to oxidative stress.22367434Behrens MI, Silva M, Salech F, Ponce DP, Merino D, Sinning M, Xiong C, Roe CM, Quest AFThe journals of gerontology. Series A, Biological sciences and medical sciencesInverse susceptibility to oxidative death of lymphocytes obtained from Alzheimer's patients and skin cancer survivors: increased apoptosis in Alzheimer's and reduced necrosis in cancer. J Gerontol A Biol Sci Med Sci. 2012 Oct; 67(10):1036-40.J Gerontol A Biol Sci Med Sci2012-02-24T00:00:002012Inverse susceptibility to oxidative death of lymphocytes obtained from Alzheimer's patients and skin cancer survivors: increased apoptosis in Alzheimer's and reduced necrosis in cancer.24669013Suraokar MB, Nunez MI, Diao L, Chow CW, Kim D, Behrens C, Lin H, Lee S, Raso G, Moran C, Rice D, Mehran R, Lee JJ, Pass HI, Wang J, Momin AA, James BP, Corvalan A, Coombes K, Tsao A, Wistuba IIAnnals of oncology : official journal of the European Society for Medical OncologyExpression profiling stratifies mesothelioma tumors and signifies deregulation of spindle checkpoint pathway and microtubule network with therapeutic implications. Ann Oncol. 2014 Jun; 25(6):1184-92.Ann Oncol2014-03-24T00:00:002014Expression profiling stratifies mesothelioma tumors and signifies deregulation of spindle checkpoint pathway and microtubule network with therapeutic implications.24850841Riquelme E, Suraokar M, Behrens C, Lin HY, Girard L, Nilsson MB, Simon G, Wang J, Coombes KR, Lee JJ, Hong WK, Heymach J, Minna JD, Wistuba IIClinical cancer research : an official journal of the American Association for Cancer ResearchVEGF/VEGFR-2 upregulates EZH2 expression in lung adenocarcinoma cells and EZH2 depletion enhances the response to platinum-based and VEGFR-2-targeted therapy. Clin Cancer Res. 2014 Jul 15; 20(14):3849-61.Clin Cancer Res2014-05-21T00:00:002014VEGF/VEGFR-2 upregulates EZH2 expression in lung adenocarcinoma cells and EZH2 depletion enhances the response to platinum-based and VEGFR-2-targeted therapy.24970476Taguchi A, Taylor AD, Rodriguez J, Celiktas M, Liu H, Ma X, Zhang Q, Wong CH, Chin A, Girard L, Behrens C, Lam WL, Lam S, Minna JD, Wistuba II, Gazdar AF, Hanash SMCancer researchA search for novel cancer/testis antigens in lung cancer identifies VCX/Y genes, expanding the repertoire of potential immunotherapeutic targets. Cancer Res. 2014 Sep 01; 74(17):4694-705.Cancer Res2014-06-26T00:00:002014A search for novel cancer/testis antigens in lung cancer identifies VCX/Y genes, expanding the repertoire of potential immunotherapeutic targets.25267614Augustyn A, Borromeo M, Wang T, Fujimoto J, Shao C, Dospoy PD, Lee V, Tan C, Sullivan JP, Larsen JE, Girard L, Behrens C, Wistuba II, Xie Y, Cobb MH, Gazdar AF, Johnson JE, Minna JDProceedings of the National Academy of Sciences of the United States of AmericaASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers. Proc Natl Acad Sci U S A. 2014 Oct 14; 111(41):14788-93.Proc Natl Acad Sci U S A2014-09-29T00:00:002014ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers.25744723Schliekelman MJ, Taguchi A, Zhu J, Dai X, Rodriguez J, Celiktas M, Zhang Q, Chin A, Wong CH, Wang H, McFerrin L, Selamat SA, Yang C, Kroh EM, Garg KS, Behrens C, Gazdar AF, Laird-Offringa IA, Tewari M, Wistuba II, Thiery JP, Hanash SMCancer researchMolecular portraits of epithelial, mesenchymal, and hybrid States in lung adenocarcinoma and their relevance to survival. Cancer Res. 2015 May 01; 75(9):1789-800.Cancer Res2015-03-05T00:00:002015Molecular portraits of epithelial, mesenchymal, and hybrid States in lung adenocarcinoma and their relevance to survival.26056316Zhu X, Xu Y, Solis LM, Tao W, Wang L, Behrens C, Xu X, Zhao L, Liu D, Wu J, Zhang N, Wistuba II, Farokhzad OC, Zetter BR, Shi JProceedings of the National Academy of Sciences of the United States of AmericaLong-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment. Proc Natl Acad Sci U S A. 2015 Jun 23; 112(25):7779-84.Proc Natl Acad Sci U S A2015-06-08T00:00:002015Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment.74Professor10Assistant Professor14Associate ProfessorAuthorship 3725617Authorship 37256216Authorship 3725636Authorship 37256812Authorship 3725693Authorship 3745766Authorship 3745771021871297Kim MP, Chen Y, Bekele BN, Lopez A, Khanna A, Chen JQ, Spitz MR, Behrens C, Solis L, Wismach M, Ji L, Wistuba II, Roth JA, Katz RLThe Annals of thoracic surgeryActivating enhancer-binding protein-2? nucleolar localization predicts poor survival after stage I non-small cell lung cancer resection. Ann Thorac Surg. 2011 Sep; 92(3):1044-50.Ann Thorac Surg2011-09-01T00:00:002011Activating enhancer-binding protein-2? nucleolar localization predicts poor survival after stage I non-small cell lung cancer resection.Authorship 841661Authorship 841946Authorship 842798Authorship 845065Authorship 845226Authorship 845400Authorship 846597Authorship 846889Authorship 848101Authorship 848191Authorship 849139Authorship 849516Authorship 850001Authorship 851237Authorship 851902Authorship 853650Authorship 854813Authorship 856970Authorship 857297Authorship 857389Authorship 859273Authorship 859514Authorship 859802Authorship 860956Authorship 862899Authorship 863085Authorship 867428American Journal of PathologyInterleukin-11 Receptor Is a Candidate Target for Ligand-Directed Therapy in Lung Cancer. American Journal of Pathology. 186:2162-2170.Interleukin-11 Receptor Is a Candidate Target for Ligand-Directed Therapy in Lung CancerClinical Cancer ResearchEpithelial-mesenchymal transition is associated with a distinct tumor microenvironment including elevation of inflammatory signals and multiple immune checkpoints in lung adenocarcinoma. Clinical Cancer Research. 22:3630-3642.Epithelial-mesenchymal transition is associated with a distinct tumor microenvironment including elevation of inflammatory signals and multiple immune checkpoints in lung adenocarcinomaOncotargetRNA-dependent protein kinase (PKR) depletes nutrients, inducing phosphorylation of AMP-activated kinase in lung cancer. Oncotarget. 6:11114-11124.RNA-dependent protein kinase (PKR) depletes nutrients, inducing phosphorylation of AMP-activated kinase in lung cancerCancer DiscoveryCo-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities. Cancer Discovery. 5:861-878.Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilitiesJournal of Clinical InvestigationZEB1 drives epithelial-to-mesenchymal transition in lung cancer. Journal of Clinical Investigation. 126:3219-3235.ZEB1 drives epithelial-to-mesenchymal transition in lung cancerNature CommunicationsThe tobacco-specific carcinogen-operated calcium channel promotes lung tumorigenesis via IGF2 exocytosis in lung epithelial cells. Nature Communications. 7.The tobacco-specific carcinogen-operated calcium channel promotes lung tumorigenesis via IGF2 exocytosis in lung epithelial cellsCancer ResearchPROTOCADHERIN 7 acts through SET and PP2A to potentiate MAPK signaling by EGFR and KRAS during lung tumorigenesis. Cancer Research. 77:187-197.PROTOCADHERIN 7 acts through SET and PP2A to potentiate MAPK signaling by EGFR and KRAS during lung tumorigenesisAmerican Journal of Cancer ResearchExpression pattern of FGFR2, Grb2 and Plcγ1 acts as a novel prognostic marker of recurrence recurrence-free survival in lung adenocarcinoma. American Journal of Cancer Research. 5:3135-3148.Expression pattern of FGFR2, Grb2 and Plcγ1 acts as a novel prognostic marker of recurrence recurrence-free survival in lung adenocarcinomaCancer ResearchIL6 blockade reprograms the lung tumor microenvironment to limit the development and progression of K-ras-mutant lung cancer. Cancer Research. 76:3189-3199.IL6 blockade reprograms the lung tumor microenvironment to limit the development and progression of K-ras-mutant lung cancerScientific ReportsLAPTM4B is associated with poor prognosis in NSCLC and promotes the NRF2-mediated stress response pathway in lung cancer cells. Scientific Reports. 5.LAPTM4B is associated with poor prognosis in NSCLC and promotes the NRF2-mediated stress response pathway in lung cancer cellsCancer ResearchModulation of EZH2 expression by MEK-ERK or PI3K-AKT signaling in lung cancer is dictated by different KRAS oncogene mutations. Cancer Research. 76:675-685.Modulation of EZH2 expression by MEK-ERK or PI3K-AKT signaling in lung cancer is dictated by different KRAS oncogene mutationsClinical Cancer ResearchImage analysis-based assessment of PD-L1 and tumor-associated immune cells density supports distinct intratumoral microenvironment groups in non-small cell lung carcinoma patients. Clinical Cancer Research. 22:6278-6289.Image analysis-based assessment of PD-L1 and tumor-associated immune cells density supports distinct intratumoral microenvironment groups in non-small cell lung carcinoma patientsCancer ResearchGenomic landscape established by allelic imbalance in the cancerization field of a normal appearing airway. Cancer Research. 76:3676-3683.Genomic landscape established by allelic imbalance in the cancerization field of a normal appearing airwayClinical Cancer ResearchAn expression signature as an aid to the histologic classification of non-small cell lung cancer. Clinical Cancer Research. 22:4880-4889.An expression signature as an aid to the histologic classification of non-small cell lung cancerNature CommunicationsGenomic heterogeneity of multiple synchronous lung cancer. Nature Communications. 7.Genomic heterogeneity of multiple synchronous lung cancerJournal of Thoracic OncologyErratum. Journal of Thoracic Oncology. 7:1065.ErratumOncotargetActivation of insulin-like growth factor 1 receptor in patients with non-small cell lung cancer. Oncotarget. 6:16746-16756.Activation of insulin-like growth factor 1 receptor in patients with non-small cell lung cancerProceedings of the National Academy of Sciences of the United States of AmericaImmunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome. Proceedings of the National Academy of Sciences of the United States of America. 113:E1555-E1564.Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcomeJournal of Thoracic OncologyValidation of SCT methylation as a hallmark biomarker for lung cancers. Journal of Thoracic Oncology. 11:346-360.Validation of SCT methylation as a hallmark biomarker for lung cancersOncogeneZEB1 induces LOXL2-mediated collagen stabilization and deposition in the extracellular matrix to drive lung cancer invasion and metastasis. Oncogene. ZEB1 induces LOXL2-mediated collagen stabilization and deposition in the extracellular matrix to drive lung cancer invasion and metastasisClinical Cancer ResearchAn integrated molecular analysis of lung adenocarcinomas identifies potential therapeutic targets among TTF1-negative tumors, including DNA Repair Proteins and Nrf2. Clinical Cancer Research. 21:3480-3491.An integrated molecular analysis of lung adenocarcinomas identifies potential therapeutic targets among TTF1-negative tumors, including DNA Repair Proteins and Nrf2OncotargetThe ISG15-specific protease USP18 regulates stability of PTEN. Oncotarget. 8:3-14.The ISG15-specific protease USP18 regulates stability of PTENProceedings of the National Academy of Sciences of the United States of AmericaASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers. Proceedings of the National Academy of Sciences of the United States of America. 111:14788-14793.ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancersBMC GenomicsCombined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterations. BMC Genomics. 16.Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterationsOncogeneMultiplatform-based molecular subtypes of non-small-cell lung cancer. Oncogene. Multiplatform-based molecular subtypes of non-small-cell lung cancerOncogeneLZTFL1 suppresses lung tumorigenesis by maintaining differentiation of lung epithelial cells. Oncogene. LZTFL1 suppresses lung tumorigenesis by maintaining differentiation of lung epithelial cellsCell ReportsPrognostic Impact of Vitamin B6 Metabolism in Lung Cancer. Cell Reports. 2:1472.Prognostic Impact of Vitamin B6 Metabolism in Lung Cancer23154545Fujimoto J, Kadara H, Garcia MM, Kabbout M, Behrens C, Liu DD, Lee JJ, Solis LM, Kim ES, Kalhor N, Moran C, Sharafkhaneh A, Lotan R, Wistuba IIJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerG-protein coupled receptor family C, group 5, member A (GPRC5A) expression is decreased in the adjacent field and normal bronchial epithelia of patients with chronic obstructive pulmonary disease and non-small-cell lung cancer. J Thorac Oncol. 2012 Dec; 7(12):1747-1754.J Thorac Oncol2012-12-01T00:00:002012G-protein coupled receptor family C, group 5, member A (GPRC5A) expression is decreased in the adjacent field and normal bronchial epithelia of patients with chronic obstructive pulmonary disease and non-small-cell lung cancer.D008214Anatomy50112350.673164LymphocytesD002289Disorders64653060.283287Carcinoma, Non-Small-Cell LungD008175Disorders1353114820.198988Lung NeoplasmsD000544Disorders2158480.563767Alzheimer DiseaseAuthorship 9141727Authorship 9152664Authorship 9252966Authorship 9261912Authorship 9275927Authorship 930414428455778Castillo S, Mu?oz P, Behrens MI, Diaz-Grez F, Segura-Aguilar JNeurotoxicity researchOn the Role of Mining Exposure in Epigenetic Effects in Parkinson's Disease. Neurotox Res. 2017 Aug; 32(2):172-174.Neurotox Res2017-04-29T00:00:002017On the Role of Mining Exposure in Epigenetic Effects in Parkinson's Disease.29051731Salech F, Ponce DP, SanMart?n CD, Rogers NK, Chac?n C, Henr?quez M, Behrens MIFrontiers in aging neurosciencePARP-1 and p53 Regulate the Increased Susceptibility to Oxidative Death of Lymphocytes from MCI and AD Patients. Front Aging Neurosci. 2017; 9:310.Front Aging Neurosci2017-10-05T00:00:002017PARP-1 and p53 Regulate the Increased Susceptibility to Oxidative Death of Lymphocytes from MCI and AD Patients.29056898P?rez MJ, Ponce DP, Osorio-Fuentealba C, Behrens MI, Quintanilla RAFrontiers in neuroscienceMitochondrial Bioenergetics Is Altered in Fibroblasts from Patients with Sporadic Alzheimer's Disease. Front Neurosci. 2017; 11:553.Front Neurosci2017-10-06T00:00:002017Mitochondrial Bioenergetics Is Altered in Fibroblasts from Patients with Sporadic Alzheimer's Disease.29472838Salech F, Ponce DP, SanMart?n CD, Rogers NK, Henr?quez M, Behrens MIFrontiers in neuroscienceCancer Imprints an Increased PARP-1 and p53-Dependent Resistance to Oxidative Stress on Lymphocytes of Patients That Later Develop Alzheimer's Disease. Front Neurosci. 2018; 12:58.Front Neurosci2018-02-08T00:00:002018Cancer Imprints an Increased PARP-1 and p53-Dependent Resistance to Oxidative Stress on Lymphocytes of Patients That Later Develop Alzheimer's Disease.29283046SanMartin CD, Henriquez M, Chacon C, Ponce DP, Salech F, Rogers NK, Behrens MICurrent Alzheimer researchVitamin D Increases A?140 Plasma Levels and Protects Lymphocytes from Oxidative Death in Mild Cognitive Impairment Patients. Curr Alzheimer Res. 2018; 15(6):561-569.Curr Alzheimer Res2018-01-01T00:00:002018Vitamin D Increases A?140 Plasma Levels and Protects Lymphocytes from Oxidative Death in Mild Cognitive Impairment Patients.30199818P?rez MJ, Ponce DP, Aranguiz A, Behrens MI, Quintanilla RARedox biologyMitochondrial permeability transition pore contributes to mitochondrial dysfunction in fibroblasts of patients with sporadic Alzheimer's disease. Redox Biol. 2018 10; 19:290-300.Redox Biol2018-09-04T00:00:002018Mitochondrial permeability transition pore contributes to mitochondrial dysfunction in fibroblasts of patients with sporadic Alzheimer's disease.PathologyD060825Disorders1703270.684182Cognitive DysfunctionAuthorship 996240132763065Behrens C, Rocha P, Parra ER, Feng L, Rodriguez-Canales J, Solis LM, Mino B, Zhang J, Gibbons DL, Sepesi B, Rice D, Heymach JV, Moran C, Creighton CJ, Lee JJ, Kadara H, Wistuba IIClinical lung cancerFemale Gender Predicts Augmented Immune Infiltration in Lung Adenocarcinoma. Clin Lung Cancer. 2021 05; 22(3):e415-e424.Clin Lung Cancer2020-06-14T00:00:002020Female Gender Predicts Augmented Immune Infiltration in Lung Adenocarcinoma.Authorship 10153562833776890Ibanez A, Yokoyama JS, Possin KL, Matallana D, Lopera F, Nitrini R, Takada LT, Custodio N, Sosa Ortiz AL, Avila-Funes JA, Behrens MI, Slachevsky A, Myers RM, Cochran JN, Brusco LI, Bruno MA, Brucki SMD, Pina-Escudero SD, Okada de Oliveira M, Donnelly Kehoe P, Garcia AM, Cardona JF, Santamaria-Garcia H, Moguilner S, Duran-Aniotz C, Tagliazucchi E, Maito M, Longoria Ibarrola EM, Pintado-Caipa M, Godoy ME, Bakman V, Javandel S, Kosik KS, Valcour V, Miller BLFrontiers in neurologyThe Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat): Driving Multicentric Research and Implementation Science. Front Neurol. 2021; 12:631722.Front Neurol2021-03-11T00:00:002021The Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat): Driving Multicentric Research and Implementation Science.Authorship 1027513434378453Farhang M, Miranda-Castillo C, Behrens MI, Castillo E, Mosquera Amar S, Rojas GAging & mental healthImpact of social isolation and coping strategies in older adults with mild cognitive impairment during the covid-19 pandemic: A qualitative study. Aging Ment Health. 2022 07; 26(7):1395-1416.Aging Ment Health2021-08-11T00:00:002021Impact of social isolation and coping strategies in older adults with mild cognitive impairment during the covid-19 pandemic: A qualitative study.Authorship 10486022035740989Espinoza S, Grunenwald F, Gomez W, Garc?a F, Abarz?a-Catalan L, Oyarce-Pezoa S, Hernandez MF, Cort?s BI, Uhrig M, Ponce DP, Dur?n-Aniotz C, Hetz C, SanMart?n CD, Cornejo VH, Ezquer F, Parra V, Behrens MI, Manque PA, Rojas-Rivera D, Vidal RL, Woehlbier U, Nassif MCellsNeuronal Rubicon Represses Extracellular APP/Amyloid ? Deposition in Alzheimer's Disease. Cells. 2022 06 07; 11(12).Cells2022-06-07T00:00:002022Neuronal Rubicon Represses Extracellular APP/Amyloid ? Deposition in Alzheimer's Disease.Authorship 1062194436430097Farhang M, Rojas G, Mart?nez P, Behrens MI, Langer ?I, Diaz M, Miranda-Castillo CInternational journal of environmental research and public healthThe Impact of a Yoga-Based Mindfulness Intervention versus Psycho-Educational Session for Older Adults with Mild Cognitive Impairment: The Protocol of a Randomized Controlled Trial. Int J Environ Res Public Health. 2022 Nov 21; 19(22).Int J Environ Res Public Health2022-11-21T00:00:002022The Impact of a Yoga-Based Mindfulness Intervention versus Psycho-Educational Session for Older Adults with Mild Cognitive Impairment: The Protocol of a Randomized Controlled Trial.Authorship 108609510Authorship 10861241038071313Prado P, Medel V, Gonzalez-Gomez R, Sainz-Ballesteros A, Vidal V, Santamar?a-Garc?a H, Moguilner S, Mejia J, Slachevsky A, Behrens MI, Aguillon D, Lopera F, Parra MA, Matallana D, Maito MA, Garcia AM, Custodio N, Funes A?, Pi?a-Escudero S, Birba A, Fittipaldi S, Legaz A, Iba?ez AScientific dataThe BrainLat project, a multimodal neuroimaging dataset of neurodegeneration from underrepresented backgrounds. Sci Data. 2023 Dec 09; 10(1):889.Sci Data2023-12-09T00:00:002023The BrainLat project, a multimodal neuroimaging dataset of neurodegeneration from underrepresented backgrounds.38168123Prado P, Medel V, Gonzalez-Gomez R, Sainz-Ballesteros A, Vidal V, Santamar?a-Garc?a H, Moguilner S, Mejia J, Slachevsky A, Behrens MI, Aguillon D, Lopera F, Parra MA, Matallana D, Maito MA, Garcia AM, Custodio N, Funes A?, Pi?a-Escudero S, Birba A, Fittipaldi S, Legaz A, Iba?ez AScientific dataAuthor Correction: The BrainLat project, a multimodal neuroimaging dataset of neurodegeneration from underrepresented backgrounds. Sci Data. 2024 Jan 02; 11(1):19.Sci Data2024-01-02T00:00:002024Author Correction: The BrainLat project, a multimodal neuroimaging dataset of neurodegeneration from underrepresented backgrounds.true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1ProfessorProfessor